Catalyst Event
Novo Nordisk A/S (NVO) · Other
From KEDI Global Obesity Care Industry Top 2+ Index (OBCI)
3/26/2026, 12:00:00 AM
Telehealth platform Hims & Hers announced it will offer Novo Nordisk's branded GLP-1 drugs Wegovy and Ozempic, resolving a prior legal dispute over compounded versions.
Korean Translation
원격의료 플랫폼 Hims & Hers가 노보 노디스크의 브랜드 GLP-1 약물인 위고비와 오젬픽을 제공할 것이라고 발표하며, 복제약 관련 이전 법적 분쟁을 해결함.
Related Recent Events
DICK'S Sporting Goods Inc (DKS) · Earnings Release
First quarter 2026 earnings release is scheduled.
5/27/2026, 12:00:00 AM
Planet Fitness Inc (PLNT) · Earnings Release
Q1 2026 earnings release on 2026-05-07 is scheduled. A typical 1-2% price movement is estimated.
5/7/2026, 12:00:00 AM
Novo Nordisk A/S (NVO) · Earnings Release
First quarter 2026 financial results announcement scheduled.
5/6/2026, 12:00:00 AM
Eli Lilly and Co (LLY) · Earnings Release
First quarter 2026 earnings release and conference call, which is estimated to have a >=10% price impact, is scheduled.
4/30/2026, 12:00:00 AM
Merck and Co Inc (MRK) · Earnings Release
Merck will report Q1 2026 earnings and host its earnings call on 2026-04-30, which is likely to be material given the strong market sensitivity to its recent guidance outlook, scheduled.
4/30/2026, 12:00:00 AM
Novartis AG (NVS) · Earnings Release
First quarter 2026 earnings results, with low impact expected from the date announcement, scheduled
4/28/2026, 12:00:00 AM